相关实验视频

Updated: Jun 1, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

在接受deucravacitinib的牛皮患者的绿色指甲

Yoshihito Mima¹, Tsutomu Ohtsuka², Yuta Norimatsu³

¹Department of Dermatology, Tokyo Metropolitan Police Hospital, Tokyo, JPN.

|January 20, 2025

概括

一个案例研究报告说,一个患者接受了治疗的deucravacitinib,一个氨酸激酶2 (Tyk2) 抑制剂的绿指甲 (GN). 这表明deucravacitinib和GN发展之间存在潜在的联系,可能是通过IL-10通路的抑制.

科学领域:

皮肤病学皮肤病学
微生物学微生物学
药理学药理学是指药理学的学科.

背景情况:

绿色指甲 (GN) 通常是由*Pseudomonas aeruginosa*引起的,通常与指甲损伤,牛皮或潮湿条件有关.
德乌克拉维西替尼 (Deucravacitinib) 是一种口服的氨酸激酶2 (Tyk2) 抑制剂,已被批准用于治疗牛皮.
介素-10 (IL-10) 信号传递对T细胞对*P. aeruginosa*的反应至关重要,而Tyk2则调解了这一途径.

研究的目的:

报告一个在deucravacitinib治疗期间出现的绿色指甲 (GN) 的新病例.
探索deucravacitinib和GN发展之间的潜在关联.
研究可能涉及Tyk2抑制和IL-10信号传递的机制.

主要方法:

一个72岁的男性患者的病例报告.
在德乌克拉维西提尼治疗四个月后,对GN发展的临床观察.
对 GN 和deucravacitinib 的现有文献的综述.

主要成果:

患者在经过四个月的德乌克拉维西提尼治疗后出现了绿色指甲 (GN).
在治疗前没有先前的指甲疾病或GN的风险因素存在.
这是第一次报告与deucravacitinib相关的GN病例.

结论:

德乌克拉维西丁尼可能有助于绿色指甲 (GN) 的发展.
该机制可能涉及deucravacitinib对Tyk2的抑制,这会损害对*Pseudomonas aeruginosa*进行打击至关重要的IL-10信号传递.
需要进一步的研究来证实这种潜在的不良影响及其潜在的病理生理学.

关键词:

需要使用deucravacitinib.绿色的指甲绿色的指甲介质蛋白-10 介质蛋白-10 的作用.这种病毒名为 Pseudomonas aeruginosa.铁氨酸激酶2的作用

更多相关视频

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...